Market closed
Phibro Animal Health/$PAHC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Phibro Animal Health
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Ticker
$PAHC
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
1,940
Website
PAHC Metrics
BasicAdvanced
$843M
48.45
$0.43
0.51
$0.48
2.31%
Price and volume
Market cap
$843M
Beta
0.51
52-week high
$24.99
52-week low
$10.04
Average daily volume
170K
Dividend rate
$0.48
Financial strength
Current ratio
3.227
Quick ratio
1.467
Long term debt to equity
192.045
Total debt to equity
199.254
Dividend payout ratio (TTM)
111.70%
Interest coverage (TTM)
3.11%
Management effectiveness
Return on assets (TTM)
5.26%
Return on equity (TTM)
6.55%
Valuation
Price to earnings (TTM)
48.448
Price to revenue (TTM)
0.806
Price to book
3.26
Price to tangible book (TTM)
5.24
Price to free cash flow (TTM)
20.734
Dividend yield (TTM)
2.31%
Forward dividend yield
2.31%
Growth
Revenue change (TTM)
7.17%
Earnings per share change (TTM)
-15.74%
3-year revenue growth (CAGR)
7.07%
3-year earnings per share growth (CAGR)
-28.99%
What the Analysts think about PAHC
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Phibro Animal Health stock.
PAHC Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PAHC Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
PAHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Phibro Animal Health stock?
Phibro Animal Health (PAHC) has a market cap of $843M as of January 22, 2025.
What is the P/E ratio for Phibro Animal Health stock?
The price to earnings (P/E) ratio for Phibro Animal Health (PAHC) stock is 48.45 as of January 22, 2025.
Does Phibro Animal Health stock pay dividends?
Yes, the Phibro Animal Health (PAHC) stock pays dividends to shareholders. As of January 22, 2025, the dividend rate is $0.48 and the yield is 2.31%. Phibro Animal Health has a payout ratio of 111.7% on a trailing twelve-month basis.
When is the next Phibro Animal Health dividend payment date?
The next Phibro Animal Health (PAHC) dividend payment date is unconfirmed.
What is the beta indicator for Phibro Animal Health?
Phibro Animal Health (PAHC) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.